Loading...
Loading...
On 15 January 2026, the Government of India announced a new Drug Procurement Policy for the Central Government Health Scheme (CGHS), which has long been awaited to introduce a change in the way medicines are procured, supplied and monitored.
About the Author
Parul Bohral, a BALLB graduate and experienced legal researcher and content writer with expertise in various legal areas, including corporate law and intellectual property. I have gained valuable experience in esteemed legal environments, where I have strengthened my research skills, allowing me to approach legal writing with precision and depth.
As a legal content writer, I am committed to delivering work that not only informs but also engages readers. By staying informed about the latest trends in content marketing and regulatory developments, I ensure that my writing remains sophisticated and meets industry standards. My dedication to thorough research enables me to craft content that is both insightful and impactful.
Related articles
CDSCO Mandates ONDLS Portal for r-DNA Drug License Applications
2026-03-16
New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13
CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26
Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20
CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12
Draft Medical Devices Rules Amendment 2025: Regulatory Changes in Registration, Labelling, and Compliance
2025-12-15